The use of monoethanolamine oleate (ethamolin®) in the treatment of lingual hemangioma




Hemangioma; Vascular system injuries; Vascular neoplasms.


A 35-year-old male patient attended the Oral and Maxillofacial Surgery and Traumatology outpatient clinic at Hospital da Face in Recife / PE, with a complaint of tongue injury.  On intra-oral clinical examination, a lesion in the lingual apex was observed and, during anamnesis, the patient reported the presence of the lesion since childhood, however, he noticed an increase in the last two years.  The vascular origin of the lesion was confirmed, suggesting a diagnosis of hemangioma.  The treatment instituted was the intralesional injection of Monoethanolamine Oleate (Ethamolin®), a sclerosing agent that has hemostatic properties and its mechanism is based on tissue necrosis.  The aim of this study was to demonstrate sclerotherapy using Ethamolin®, which proved to be a viable, safe and effective therapeutic option in the resolution of the reported vascular neoplasia.  The patient was followed up for three months and showed complete remission of the lesion without recurrences.


Agarwal, M., Agarwal, L. & Mathur, V. (2018). Hemangioma of tongue. AME Case Reports, 2: 11.

Almeida, A. C. & Camargo W. R. (2014). Hemangioma bucal: tratamentos preconizados. Brazilian Journal of Surgery and Clinical Research, 8(2): 59-61.

Carvalho, S., Machado, S. & Selores, M. (2016). Hemangioma infantil e propranolol oral – recomendações atuais. Nascer e Crescer: revista de pediatria do centro hospitalar do porto, 25(3): 154-158.

Cruz, F. L. G, et al. (2011). Differential diagnosis of hemangioma by diascopy. Revista Gaúcha de Odontologia, 59(1): 125-129.

Diniz, D. A., et al. (2020). Tratamento com óleo de etanolamina 5% em Hemangioma oral em paciente idoso: relato de caso. Research, Society and Development, 9(9): e675997970.

Fernandes, D. T., et al. (2018). Benign oral vascular lesions treated by sclerotherapy with ethanolamine oleate: A retrospective study of 43 patients. Med Oral Patol Oral Cir Bucal. Mar 1,23 (2):e180-7.

Gomes, J. A. & Ramalho, L. M. P. (2019). Escleroterapia como tratamento conservador para hemangioma oral: relato de caso. Revista de Ciências Médicas e Biológicas, 18(3): 421-424.

Mandú, A. L. C., et al. (2013). Escleroterapia de hemangioma: relato de caso. Revista de Cirurgia e Traumatologia Buco-Maxilo-Facial, 13(1): 71-76.

Neves, L. E. M., et al. (2018). Lesões vasculares orais: avaliações clínicas, diagnósticas e terapêuticas. Revista Cubana de Estomatología, 55(4): 1-11.

Oliveira, M. M. M. & Silva, B. A. (2020). Sclerotherapy as treatment of lingual hemangioma: clinical case report. Revista Gaúcha de Odontologia, 68:e20200017

Pereira, A. S., et al. (2018). Metodologia da pesquisa científica. UAB/NTE/UFSM. c_Computacao_Metodologia - Pesquisa - Cientifica.pdf?sequence=1.

Portaro, S., et al. (2018). Hemangiomas of the tongue and the oral cavity in a myotonic dystrophy type 1 patient: A case report. Medicine, 97(48): e13448.

Queiroz, S. B. F., et al. (2016). Severe Edema After Sclerotherapy of Labial Hemangioma With Ethamolin Oleate in a Young Child. The Journal of Craniofacial Surgery, 27(6): e567-8.

Queiroz, S. I. M. L., et al. (2014). Tratamento de hemangioma oral com escleroterapia: relato de caso. Jornal Vascular Brasileiro, 13(3): 249-253.

Sales, P. H. H., et al. (2015). Utilização De Agente Esclerosante No Tratamento De Hemangioma Lingual: Relato De Caso. Revista de Odontologia da Universidade Cidade de São Paulo, 27(3): 253-257.

Shrestha, A. L. & Paudel, S. B. (2018). Lingual cavernous hemangioma in a Nepalese boy— ‘A Difficult Associate!!!’. Journal of Surgical Case Reports, (10): rjy283

Silva, J. R., et al. (2016) O uso de Oleato de Monoetanolamina no tratamento de Hemangioma em lábio inferior: relato de caso. Odontologia Clínico-Científica, 15(2): 127 - 129.



How to Cite

FERREIRA, S. P. R.; SILVA, C. P. da; OLIVEIRA, . R. S. de; ANDRADE, M. G. de; SOUSA JÚNIOR, J. R. S. de; SILVA NETO, J. C. da. The use of monoethanolamine oleate (ethamolin®) in the treatment of lingual hemangioma. Research, Society and Development, [S. l.], v. 10, n. 1, p. e38410111817, 2021. DOI: 10.33448/rsd-v10i1.11817. Disponível em: Acesso em: 28 feb. 2021.



Health Sciences